Immunization with C5a Peptidase or Peptidase-Type III Polysaccharide Conjugate Vaccines Enhances Clearance of Group B Streptococci from Lungs of Infected Mice

Group B streptococci (GBS) are among the most common causes of life-threatening neonatal infections. Vaccine development since the late 1970s has focused on the capsular polysaccharides, but a safe, effective product is still not available. Our quest for a vaccine turned to the streptococcal C5a pep...

全面介紹

書目詳細資料

發表在:	Infect Immun
Principais autores:	Cheng, Qi, Debol, Steven, Lam, Hong, Eby, Ron, Edwards, Lorri, Matsuka, Yury, Olmsted, Stephen B., Cleary, P. Patrick
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2002
主題:	Microbial Immunity and Vaccines
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130386/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12379721/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.11.6409-6415.2002
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!